TBA BPaL Access_ Data on the timelines, prices, volumes, interventions and actors involved v2.0

This file is an updated version of the dataset originally posted in July 2025 at https://zenodo.org/records/16571036. The worksheets in this spreadsheet provide the data underlying the statistics and figures in the article submitted to BMJ Global Health, "Orchestrating faster access to products of non-profit R&D: A case study of a novel regimen for drug-resistant tuberculosis," which is based on the longer research report "Orchestrating faster access to products of non-profit R&D: Insights from the case of BPaL/M for tuberculosis" published by the Global Health Centre, Geneva Graduate Institute (July 2025). Most of the data was collected and provided by the TB Alliance to the research team (Suerie Moon, Marcela Vieira, Kaitlin Large). The research team amended the figures and also collected the data for Figure 5.本文件为2025年7月发布于https://zenodo.org/records/16571036的原始数据集的更新版本。本电子表格内的工作表提供了投稿至《英国医学杂志·全球卫生》（BMJ Global Health）的论文《统筹加快非营利研发产品可及性：耐药结核病新型治疗方案案例研究》中统计数据与图表的原始数据。该论文基于日内瓦高级国际关系及发展学院全球卫生中心（Global Health Centre, Geneva Graduate Institute）于2025年7月发布的长篇研究报告《统筹加快非营利研发产品可及性：BPaL/M结核病治疗案例的启示》。本研究所需的绝大多数数据由结核病联盟（TB Alliance）收集并提供给研究团队（Suerie Moon、Marcela Vieira、Kaitlin Large）。本研究团队对相关图表进行了修订，并额外收集了图5的对应数据。